www.uspto.gov
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and TrademarkOffice
`Address; COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`
`16/892,774
`
`06/04/2020
`
`Noritaka IGUCHI
`
`2020-1459
`
`1058
`
`iE
`Lind&
`Wenderoth,
`Wenderoth, Lind & Ponack, L.L.P.
`1025 Connecticut Avenue, NW
`Suite 500
`Washington, DC 20036
`
`MENGESHA, MULUGETA A
`
`2424
`
`PAPER NUMBER
`
`NOTIFICATION DATE
`
`DELIVERY MODE
`
`11/16/2021
`
`ELECTRONIC
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period for reply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the
`following e-mail address(es):
`eoa@ wenderoth.com
`kmiller@wenderoth.com
`
`PTOL-90A (Rev. 04/07)
`
`

`

`Applicant(s)
`Application No.
`rrect
`IGUCHIetal.
`16/892,774
`Noth Comrectod Diff
`
`
`otice of Art Unit|AIA (FITF) StatusAHowability Examiner
`
`MULUGETA MENGESHA
`2424
`Yes
`
`.
`
`2._) Anelection was madebythe applicant in responseto a restriction requirementset forth during the interview on
`restriction requirement and election have been incorporatedinto this action.
`
`; the
`
`3.{¥) The allowed claim(s) is/are 9-12 . As a result of the allowed claim(s), you maybeeligible to benefit from the Patent Prosecution
`Highwayprogram at a participating intellectual property office for the corresponding application. For more information, please see
`http:/Awww.uspto.gov/patents/init_events/pph/index.jsp or send an inquiry to PPHfeedback@uspto.gov.
`
`4[¥] Acknowledgmentis made of a claim for foreign priority under 35 U.S.C. § 119(a)-(d) or (f).
`Certified copies:
`c) () Noneofthe:
`a) MAI
`b) (] Some*
`1. ( Certified copies of the priority documents have been received.
`2.¥)Certified copies of the priority documents have been received in Application No. 15075229 .
`3. (1 Copies of the certified copies of the priority documents have been receivedin this national stage application from the
`International Bureau (PCT Rule 17.2(a)).
`
`“ Certified copies not received:
`
`-- The MAILING DATEof this communication appears on the cover sheet with the correspondence address--
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application. If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANTOF PATENTRIGHTS.This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`1{¥] This communication is responsive to 09/29/2021.
`(J A declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/werefiled on
`
`Primary Examiner, Art Unit 2424
`
`Applicant has THREE MONTHS FROM THE "MAILING DATE"of this communication to file a reply complying with the requirements
`noted below.Failure to timely comply will result in ABANDONMENT ofthis application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`5] CORRECTED DRAWINGS (as "replacement sheets") must be submitted.
`() including changes required by the attached Examiner's Amendment / Commentor in the Office action of
`Paper No./Mail Date
`.
`Identifying indicia such as the application number (see 37 CFR 1.84(c)) should be written on the drawingsin the front (not the back) of each
`sheet. Replacement sheet(s) should be labeled as such in the header according to 37 CFR 1.121(d).
`
`6.1] DEPOSIT OFand/or INFORMATION aboutthe deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner's comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1.) Notice of References Cited (PTO-892)
`2.) Information Disclosure Statements (PTO/SB/08),
`Paper No./Mail Date
`.
`3. Examiner's Comment Regarding Requirementfor Deposit
`of Biological Material
`.
`4.() Interview Summary (PTO-413),
`Paper No./Mail Date.
`/Mulugeta Mengesha/
`
`5. C) Examiner's Amendment/Comment
`6. (J Examiner's Statement of Reasonsfor Allowance
`
`7. CJ Other
`
`.
`
`U.S. Patent and Trademark Office
`PTOL-37 (Rev. 08-13)
`
`Notice of Allowability
`
`.
`Part of Paper No./Mail Date 20211111
`
`